289 related articles for article (PubMed ID: 15795708)
1. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
Boomsma F; Hut H; Bagghoe U; van der Houwen A; van den Meiracker A
Med Sci Monit; 2005 Apr; 11(4):RA122-6. PubMed ID: 15795708
[TBL] [Abstract][Full Text] [Related]
2. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
3. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
6. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
7. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
[TBL] [Abstract][Full Text] [Related]
8. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes].
Dura E; Mészáros Z; Salacz G; Magyar K; Romics L; Karádi I
Orv Hetil; 2002 Nov; 143(47):2637-44. PubMed ID: 12532650
[TBL] [Abstract][Full Text] [Related]
9. Alterations in plasma semicarbazide-sensitive amine oxidase activity in hypertensive heart disease with left ventricular systolic dysfunction.
Marinho C; Arduíno D; Falcão LM; Bicho M
Rev Port Cardiol; 2010 Jan; 29(1):37-47. PubMed ID: 20391898
[TBL] [Abstract][Full Text] [Related]
10. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure.
Boomsma F; de Kam PJ; Tjeerdsma G; van den Meiracker AH; van Veldhuisen DJ
Eur Heart J; 2000 Nov; 21(22):1859-63. PubMed ID: 11052858
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
[TBL] [Abstract][Full Text] [Related]
14. Production of a truncated soluble human semicarbazide-sensitive amine oxidase mediated by a GST-fusion protein secreted from HEK293 cells.
Ohman J; Jakobsson E; Källström U; Elmblad A; Ansari A; Kalderén C; Robertson E; Danielsson E; Gustavsson AL; Varadi A; Ekblom J; Holmgren E; Doverskog M; Abrahmsén L; Nilsson J
Protein Expr Purif; 2006 Apr; 46(2):321-31. PubMed ID: 16325418
[TBL] [Abstract][Full Text] [Related]
15. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
[TBL] [Abstract][Full Text] [Related]
16. On the primary structure of membrane-bound semicarbazide-sensitive amine oxidase (SSAO).
Lizcano JM; Unzeta M
Neurobiology (Bp); 2000; 8(1):37-46. PubMed ID: 11008876
[TBL] [Abstract][Full Text] [Related]
17. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging.
del Mar Hernandez M; Esteban M; Szabo P; Boada M; Unzeta M
Neurosci Lett; 2005 Aug 12-19; 384(1-2):183-7. PubMed ID: 15894424
[TBL] [Abstract][Full Text] [Related]
18. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
Conklin DJ; Langford SD; Boor PJ
Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
[TBL] [Abstract][Full Text] [Related]
19. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
Bour S; Daviaud D; Gres S; Lefort C; Prévot D; Zorzano A; Wabitsch M; Saulnier-Blache JS; Valet P; Carpéné C
Biochimie; 2007 Aug; 89(8):916-25. PubMed ID: 17400359
[TBL] [Abstract][Full Text] [Related]
20. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure.
Boomsma F; van Veldhuisen DJ; de Kam PJ; Man in't Veld AJ; Mosterd A; Lie KI; Schalekamp MA
Cardiovasc Res; 1997 Feb; 33(2):387-91. PubMed ID: 9074703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
